ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,306.04
      0.02%
      US Tech 100
      18,375.20
      0.31%
      Dow Jones
      38,852.86
      -0.55%
      Brent Oil
      84.145
      -0.21%
      Bitcoin
      68,528.75
      0.35%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Surface Oncology Inc (SURF)

      7. Surface Oncology Inc (SURF) News

      SURF

      Surface Oncology (SURF)

      Surface Oncology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SURF
      DateTimeSourceHeadlineSymbolCompany
      09/13/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SURFSurface Oncology Inc
      09/13/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SURFSurface Oncology Inc
      09/08/20234:10PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
      09/08/20234:09PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
      09/08/20234:08PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
      09/08/20234:07PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
      09/08/20234:06PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
      09/08/20234:05PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
      09/08/20234:04PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SURFSurface Oncology Inc
      09/08/20234:03PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SURFSurface Oncology Inc
      09/08/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      09/08/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      09/08/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      09/08/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      09/08/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      09/08/20239:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SURFSurface Oncology Inc
      08/31/20235:18PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SURFSurface Oncology Inc
      08/31/20234:01PMGlobeNewswire Inc.Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciencesNASDAQ:SURFSurface Oncology Inc
      08/30/20234:34PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SURFSurface Oncology Inc
      08/30/20234:32PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SURFSurface Oncology Inc
      08/30/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SURFSurface Oncology Inc
      08/11/20238:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      08/11/20238:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      08/11/20238:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
      08/02/20237:06AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SURFSurface Oncology Inc
      08/02/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SURFSurface Oncology Inc
      08/02/20237:00AMGlobeNewswire Inc.Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023NASDAQ:SURFSurface Oncology Inc
      07/26/20234:56PMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:SURFSurface Oncology Inc
      07/20/20238:00AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SURFSurface Oncology Inc
      07/12/20235:08PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SURFSurface Oncology Inc
       Showing the most relevant articles for your search:NASDAQ:SURF